Standout Papers

Fixed-Dose Combinations Improve Medication Compliance: A Meta-Analysis 2007 2026 2013 2019 769
  1. Fixed-Dose Combinations Improve Medication Compliance: A Meta-Analysis (2007)
    Sripal Bangalore, Gayathri Kamalakkannan et al. The American Journal of Medicine
  2. Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation (2025)
    Christian T. Ruff, Siddharth M. Patel et al. New England Journal of Medicine

Immediate Impact

2 from Science/Nature 60 standout
Sub-graph 1 of 18

Citing Papers

Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial
2024 Standout
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
2024 Standout
2 intermediate papers

Works of Sanobar Parkar being referenced

A Meta-Analysis of 94,492 Patients With Hypertension Treated With Beta Blockers to Determine the Risk of New-Onset Diabetes Mellitus
2007

Author Peers

Author Last Decade Papers Cites
Sanobar Parkar 664 293 237 306 15 1.4k
Patricia Montague 520 214 284 398 9 1.8k
Alan N. Unger 572 93 173 262 15 1.8k
Robert S. Young 617 279 61 408 22 2.0k
Virginia Flintoft 467 272 84 273 21 1.8k
Anick Bérard 367 407 316 180 39 1.8k
Gordon M. Saperia 197 297 101 183 20 1.6k
Jon-David Schwalm 975 309 147 163 65 2.2k
Feride Frech 340 334 518 129 41 1.9k
Jacques LeLorier 317 422 257 123 24 1.8k
David A. Woodwell 188 171 82 101 15 2.0k

All Works

Loading papers...

Rankless by CCL
2026